TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/21/23 18:07 | 8/17/23 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ayabudge LLC | NC | T | S.m | -6,379 | 3.54 | 0 | -1,800 | -18 | 8,191 | D | |||||||||||||||
6/16/23 16:04 | 6/15/23 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ayabudge LLC | NC | T | S | -1,559 | 3.12 | 0 | -500 | -5 | 9,991 | D | |||||||||||||||
6/15/23 16:17 | 6/13/23 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ayabudge LLC | NC | T | S | -12,675 | 2.60 | 0 | -4,875 | -32 | 10,491 | D | |||||||||||||||
5/26/23 17:02 | 5/25/23 | HUMA | Humacyte, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ayabudge LLC | NC | T | S | -7,219 | 2.75 | 0 | -2,625 | -15 | 15,366 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |